Journal for ImmunoTherapy of Cancer Impact Factor, Indexing, Ranking 2024

The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.

《癌症免疫治疗杂志》（Journal for ImmunoTherapy of Cancer，简称 JITC）系由癌症免疫治疗学会（Society for Immunotherapy of Cancer，简称 SITC）主办的开放获取、同行评审的在线期刊。该期刊致力于发表关于肿瘤免疫学及癌症免疫治疗各方面的研究成果，通过此举旨在丰富该领域众多利益相关者之间的交流，并推动科学认识的深入。感兴趣的主题涵盖了基础科学、转化医学至临床应用的全谱系，包括肿瘤与宿主相互作用、肿瘤微环境、动物模型、预测性和预后性免疫生物标志物、新型药物和细胞治疗、疫苗、基于免疫的组合疗法以及免疫相关毒性等。